01OverviewDefinition, clinical context and the essential points that orientate the chapter.
Diabetic distal symmetrical polyneuropathy is a length-dependent disorder of sensory, motor and autonomic axons. Positive symptoms include burning, electric pain, tingling and allodynia; negative symptoms include numbness, loss of temperature and absent proprioception. Ankle reflexes fall, vibration is impaired and distal weakness can appear later. Small-fibre pain may precede abnormal routine nerve conduction. The practical priority is protective sensation: a patient who feels no pain can walk on an ulcer, foreign body or Charcot injury. At every relevant review remove socks and shoes, inspect skin and between toes, assess pulses, temperature, deformity and monofilament or other validated sensation, and allocate foot-risk follow-up under NICE guidance. Sudden unilateral foot warmth, swelling or shape change is possible active Charcot neuroarthropathy even when radiographs or pain are initially unremarkable.
Diabetic neuropathy is broader than the stocking pattern. Autonomic damage can cause postural hypotension, resting tachycardia, gastroparesis, diarrhoea or constipation, bladder dysfunction, erectile dysfunction, sweating change and impaired hypoglycaemia awareness. Diabetic lumbosacral radiculoplexus neuropathy typically causes acute severe thigh or hip pain followed by asymmetric proximal weakness, weight loss and later spread; it needs neurology review and exclusion of structural or malignant disease. Median and ulnar entrapments are more common. A third-nerve palsy with pupil sparing can be microvascular, but any pupil involvement or atypical features requires urgent imaging. Glycaemic improvement reduces future risk, but pain and autonomic symptoms need direct management and overly rapid correction can occasionally cause treatment-induced neuropathy.
Chronic harmful alcohol exposure commonly produces a slowly progressive painful length-dependent axonal neuropathy. Assess dose, duration, withdrawal risk, meals, weight loss, vomiting, bariatric or pancreatic disease and other toxins. Thiamine deficiency may coexist with encephalopathy or cardiomyopathy; deficiencies of B12, folate, copper and other nutrients and liver or renal disease should be considered from context. Treatment combines supported reduction or abstinence, safe withdrawal planning, adequate diet, vitamin replacement and physical and foot care. Neuropathic analgesics reduce pain but not numbness or injury risk. Duloxetine may suit painful diabetic neuropathy; amitriptyline may worsen postural or autonomic symptoms; gabapentinoids require renal adjustment and dependence precautions. Agree functional goals, switch rather than stack ineffective drugs and avoid routine long-term opioids.
Key points
- Distal symmetrical diabetic polyneuropathy usually begins in toes with sensory loss, burning or allodynia, spreads proximally and later affects hands when leg involvement is advanced.
- Loss of protective sensation may be painless and is more dangerous than pain: inspect feet, pulses, skin, deformity and footwear and place risk into the NICE diabetic-foot pathway.
- Diabetes also causes autonomic neuropathy, entrapment neuropathies, radiculoplexus neuropathy and cranial mononeuropathies; asymmetry or proximal wasting is not routine stocking neuropathy.
- Optimise glucose safely and manage blood pressure, lipids, smoking, renal disease and weight, but explain that established axonal loss may not reverse quickly.
- Very rapid improvement in chronic severe hyperglycaemia can rarely precipitate treatment-induced painful and autonomic neuropathy, so severe new pain after a large HbA1c fall deserves review.
- Alcohol-related neuropathy reflects direct toxicity plus thiamine and other nutritional deficiencies, liver disease and social factors; quantify intake and dietary adequacy non-judgementally.
- Give parenteral thiamine for suspected Wernicke encephalopathy or high-risk acute illness and follow the alcohol pathway; oral replacement alone is not adequate for Wernicke disease.
- For neuropathic pain, NICE initial options are amitriptyline, duloxetine, gabapentin or pregabalin, chosen by comorbidity, function, misuse risk and patient preference.
- Do not anchor on diabetes or alcohol when weakness is rapid, asymmetrical, proximal or demyelinating, because B12 deficiency, CIDP, vasculitis, compression and medicines may coexist.
02AetiologyUnderlying causes, associations and risk factors, with why each one matters.
Chronic diabetic nerve injury
Chronic diabetes can cause a length-dependent polyneuropathy affecting sensory, motor and autonomic axons, with distal sensory loss usually appearing first.
Alcohol and nutritional toxicity
Sustained alcohol exposure can directly injure axons and commonly coexists with thiamine or other nutrient deficiency, liver disease and poor dietary intake.
Coexisting neuropathy
Entrapment, vitamin B12 deficiency, medicine toxicity, amyloid and immune demyelination may occur alongside diabetes or alcohol use and explain atypical asymmetry or rapid progression.
03PathophysiologyThe causal sequence from the underlying abnormality to symptoms and harm.
- 1Metabolic and toxic axonal stress
Chronic hyperglycaemia and alcohol-related direct or nutritional toxicity injure peripheral axons through different metabolic pathways that can coexist.
- 2Length-dependent axonal loss
Distal sensory fibres fail first, causing numbness, burning and loss of protective sensation before weakness spreads proximally or reaches the hands.
- 3Autonomic and motor involvement
Continuing fibre loss affects vasomotor, gastrointestinal, bladder and cardiac control and eventually denervates distal muscles, altering gait and foot mechanics.
04Clinical features and red flagsSymptoms, examination findings, patterns of presentation and time-critical warnings.
Symmetrical toe-first sensory loss or burning with reduced ankle reflexes and later distal weakness is the common diabetic length-dependent pattern.
Inability to detect monofilament pressure, temperature or injury identifies ulcer risk even if the patient reports no neuropathic pain.
A unilateral hot, red or swollen foot with neuropathy, sometimes after minor trauma and with little pain, needs immediate offloading and specialist diabetic-foot assessment.
Postural symptoms, gastroparesis, bladder or sexual dysfunction, sweating change and lost hypoglycaemia warning suggest multi-organ autonomic nerve involvement.
Painful symmetrical distal sensory symptoms with heavy prolonged alcohol use, poor diet, weight loss or other deficiency signs supports combined toxic-nutritional neuropathy.
Marked proximal weakness, rapid progression, upper-limb-first disease, asymmetry or generalized demyelinating findings should prompt investigation beyond diabetes or alcohol attribution.
05InvestigationsWhat to request, why it matters and how to interpret it.
Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.
- 01
Full diabetic foot examinationFirst step - Why
- Detect ulceration, callus, deformity, infection, ischaemia and loss of protective sensation and assign risk.
- Interpretation and limitations
- Ulcer, active Charcot change, spreading infection or critical ischaemia activates urgent foot-service pathways; absence of pain is not reassuring.
- 02
HbA1c and metabolic review - Why
- Assess chronic glycaemic exposure and guide safe risk-factor management without assuming causation from one value.
- Interpretation and limitations
- A high or rapidly falling HbA1c informs management; an atypical neurological pattern still needs investigation for a second process.
- 03
Nutrition, organ and blood assessment - Why
- Look for thiamine or B12 risk, folate deficiency, anaemia, renal, liver and thyroid contributors in alcohol or diabetes.
- Interpretation and limitations
- Replace confirmed or high-risk deficiencies through the correct route and treat organ disease; several contributors commonly coexist.
- 04
Postural and autonomic testing - Why
- Document orthostatic blood pressure and pulse change and evaluate history-led gastrointestinal, bladder, sexual or sudomotor dysfunction.
- Interpretation and limitations
- Medication, dehydration and cardiac disease can mimic autonomic neuropathy; severe or multisystem dysfunction may need specialist autonomic assessment.
- 05
Nerve-conduction studies and EMG - Why
- Clarify rapid, motor, asymmetric, proximal or otherwise atypical neuropathy and identify demyelination or plexus disease.
- Interpretation and limitations
- Typical stable distal neuropathy may not need testing; conduction block or disproportionate slowing should trigger CIDP or entrapment review.
- 06
Alcohol and dependence assessment - Why
- Quantify intake, withdrawal risk, nutrition and psychosocial need to create a medically safe change plan.
- Interpretation and limitations
- Abrupt cessation can be dangerous in dependence; coordinate assisted withdrawal and relapse-prevention support rather than giving unsupported abstinence advice.
06Differential diagnosisRealistic alternatives and the features that help distinguish them.
Vitamin B12 or thiamine deficiency
Sensory ataxia, cognitive change, anaemia or corticospinal signs suggest nutritional disease; deficiency can coexist with alcohol exposure or metformin use.
CIDP
Prominent proximal weakness, rapid or relapsing evolution and acquired demyelinating neurophysiology support CIDP rather than routine length-dependent axonal neuropathy.
Vasculitic neuropathy
Severe pain with stepwise asymmetric involvement of separate named nerves suggests mononeuritis multiplex and requires urgent inflammatory assessment.
Entrapment or radiculopathy
A focal named-nerve or dermatomal pattern with corresponding weakness and reflex change indicates local compression despite a background polyneuropathy.
07ManagementImmediate care, first-line treatment, alternatives and escalation.
01Foot firstProtect tissue before treating painFirst stepDiabetes or alcohol-related sensory loss affects the feet.+
- 1Inspect bare feet, interdigital spaces, nails, callus, deformity, temperature and footwear, assess pulses and protective sensation and ask about prior ulcer or amputation.
- 2Refer ulcer, infection, ischaemia or suspected active Charcot change at the urgency specified by the NICE diabetic-foot pathway and offload where advised.
- 3Provide daily self-inspection, washing, moisturising away from toe spaces, footwear and thermal-injury advice adapted to vision and dexterity.
- 4Arrange podiatry and risk-based surveillance, ensuring pain improvement never substitutes for ongoing protective care.
02Cause and riskModify metabolic and alcohol driversAlternativeA typical length-dependent neuropathy is confirmed without an acute alternative.+
- 1Optimise glucose and cardiovascular risk through shared diabetes care, avoiding destabilisingly rapid correction and acknowledging that nerve recovery is slow.
- 2Quantify alcohol, diet and withdrawal risk; arrange assisted withdrawal or community support and parenteral thiamine when acute Wernicke risk is present.
- 3Check history-led nutritional, renal, liver, thyroid and medicine contributors and correct each without assuming one abnormality explains the whole phenotype.
- 4Add physiotherapy, falls, orthotic and occupational support for weakness, balance and work-related injury prevention.
03PainUse functional trials, not indefinite stackingBurning, allodynia or electric pain impairs sleep, mobility or participation.+
- 1Agree a functional target and choose amitriptyline, duloxetine, gabapentin or pregabalin based on autonomic symptoms, renal function, mood, falls and misuse risk.
- 2Start low, titrate one medicine to an adequate tolerated trial and review pain interference, alertness, gait and adverse effects.
- 3If ineffective or not tolerated, taper safely and switch to another NICE option rather than accumulating sedating combinations.
- 4Refer severe refractory pain or diagnostic uncertainty to specialist care, while continuing foot protection and causal treatment.
Key medicines and prescribing safety4 treatments · regimens, roles and cautions+
Duloxetine
For painful diabetic neuropathy, commonly start 30 mg once daily and increase to 60 mg daily if tolerated under current BNF guidance.Review blood pressure, nausea, liver disease, renal function, sexual effects, suicidality and serotonergic interactions; taper gradually when stopping.
Pregabalin
Begin with a low divided daily dose, adjust for renal function and titrate only to the lowest exposure that gives meaningful functional benefit.Somnolence, dizziness, oedema, weight gain, falls, misuse, dependence and respiratory depression with opioids require controlled supply and gradual withdrawal.
Parenteral thiamine
Use the local high-potency intravenous or intramuscular regimen for suspected Wernicke encephalopathy or high-risk harmful drinking during acute illness.Oral treatment is inadequate for suspected Wernicke disease; administer where rare anaphylaxis can be treated and never delay urgent glucose for hypoglycaemia.
Capsaicin cream
Apply the low-concentration licensed cream to a small localised painful area according to product frequency and duration, avoiding broken skin.Initial burning and local irritation are common; wash hands, avoid eyes and mucosa, and do not confuse this with the specialist high-concentration patch.
08ComplicationsImportant consequences, why they occur and why they matter clinically.
Foot ulcer, infection and amputation
Loss of pain, deformity and impaired healing permit unnoticed pressure or trauma to progress to ulceration, osteomyelitis and limb-threatening infection.
Falls and fractures
Proprioceptive loss, foot drop, postural hypotension and alcohol-related imbalance combine to destabilise gait and cause injury.
Autonomic organ dysfunction
Orthostatic hypotension, gastroparesis, diarrhoea, bladder dysfunction and erectile difficulty can cause syncope, malnutrition, infection and major quality-of-life loss.
Chronic neuropathic pain
Burning, allodynia and sleep disruption may persist despite improved metabolic control, contributing to depression, sedating medicine exposure and functional decline.
09Monitoring and follow-upTreatment response, safety checks and longer-term review.
- Repeat foot-risk assessment at the NICE-defined interval and at any new blister, callus, colour, temperature or shape change; examine rather than relying on symptoms.
- Track HbA1c trajectory, hypoglycaemia warning, postural blood pressure, weight and renal function as metabolic and autonomic care evolves.
- In harmful alcohol use monitor nutrition, withdrawal risk, liver and haematological status, engagement and recurrence without punitive discharge after relapse.
- For pain medicines record sleep and walking benefit, sedation, falls, mood, oedema, weight, misuse and withdrawal at every titration or repeat review.
- Reopen neurophysiological or specialist investigation for rapid progression, proximal or asymmetric weakness, upper-limb predominance or unexpected reflex loss.
10Special situationsVariants, exceptions and circumstances that change the usual approach.
Numb can be dangerous
Pain drives attendance, but painless loss of protective sensation is the stronger predictor of unnoticed trauma and ulceration.
Warmth precedes collapse
Active Charcot neuroarthropathy may begin with unilateral heat and swelling before dramatic radiographic destruction, making early offloading critical.
Glucose change can hurt
Rare treatment-induced neuropathy follows a rapid large glycaemic improvement and can combine severe small-fibre pain with autonomic dysfunction.
Alcohol acts by several routes
Direct axonal toxicity, poor intake, malabsorption, liver disease and deficiencies can converge, so vitamin prescription alone is rarely complete treatment.
Diabetes is common enough to coexist
Because diabetes is prevalent, it can be present alongside CIDP, B12 deficiency or compression; discordant motor or asymmetric signs deserve fresh localisation.
11Common pitfallsFrequent interpretation and management errors.
- 01
Renewing neuropathic analgesia without removing socks, inspecting skin and assigning diabetic foot risk.
- 02
Reassuring a patient because a hot swollen Charcot foot is minimally painful or an early plain radiograph is unremarkable.
- 03
Attributing rapid proximal weakness or stepwise asymmetry to routine diabetic neuropathy and missing inflammatory or vasculitic disease.
- 04
Advising abrupt alcohol cessation to a dependent person without assessing seizure, delirium and medically assisted withdrawal needs.
- 05
Using oral thiamine as sole treatment for suspected Wernicke encephalopathy during acute harmful drinking and malnutrition.
- 06
Combining multiple sedating neuropathic-pain drugs without adequate monotherapy trials, renal adjustment, functional review or withdrawal planning.